21 SEPTEMBER NEW ZEALAND GAZETTE 3311

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Meropenem trihydrate 570 mg (equivalent to 500 mg anhydrous meropenem in 10 mL) and sodium carbonate 34.68 mg in 2 mL as diluent Powder for IM injection (vial) Sumitomo Pharmaceutical Co Limited, Ibaraki-Shi, Osaka, Japan and Zambon Group SpA., Vicenza, Italy (diluent only) Merrem IM

Meropenem trihydrate 285 mg, 570 mg, 1.14 g (equivalent to 250 mg in 10 mL, 500 mg in 20 mL, 1 g in 30 mL anhydrous meropenem) Powder for IV injection (vial) Sumitomo Pharmaceutical Co Limited, Ibaraki-Shi, Osaka, Japan Merrem IV

Abciximab 2 mg/ mL in 5 mL and 20 mL Solution for injection (vials) Centocor BV., Leiden, The Netherlands Reopro

Sparfloxacin 100 mg, 200 mg Tablets Rhone Poulenc Rorer Pharmaceuticals Limited, Nenagh, Co. Tipperary, Republic of Ireland Zagam

Dated this 12th day of September 1995.

KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.

g6164

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Megestrol acetate 40 mg/mL in 240 mL Suspension (oral) U S Pharmaceutical Group, Evansville, Indiana, United States of America Megostat

Lisinopril 5 mg, 10 mg, 20 mg Tablets Laboratoires Merck Sharp & Dohme-Chibret (Mirabel Plant), Riom, France and Merck Sharp & Dohme (Aust) Pty Limited, South Granville, New South Wales, Australia Prinivil

Cyclosporin A 25 mg, 100 mg Capsules Sandoz Pharma Limited, Basle, Switzerland Sandimmun
Cyclosporin A 100 mg per mL in 50 mL Solution (oral) Sandoz Pharma Limited, Basle, Switzerland Sandimmun

Lisinopril dihydrate 5 mg, 10 mg, 20 mg, 40 mg, 80 mg Tablets Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zestril

Amantadine hydrochloride 100 mg Capsule R P Scherer GmbH, Eberbach, Germany Symmetrel

Simvastatin 5 mg, 10 mg, 20 mg, 40 mg Tablets Merck & Co Inc., West Point, Pennsylvania, United States of America and Merck Sharp & Dohme (Aust) Pty Limited, South Granville, New South Wales, Australia Zocor

Dated this 12th day of September 1995.

KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.

g6166

Inland Revenue

Income Tax Act 1994

Determination DEP10: Tax Depreciation Rates General Determination Number 10

Pursuant to section EG 14 of the Income Tax Act 1994, notice is hereby given that the Commissioner of the Inland Revenue Department has issued “Determination DEP10: Tax Depreciation Rates General Determination Number 10”, pursuant to section EG 4 of the Income Tax Act 1994. The determination may be cited as “Determination DEP10: Tax Depreciation Rates General Determination Number 10”. The determination is available from Inland Revenue offices.

Dated at Wellington this 15th day of September 1995.

C. NEIL, Manager (Rulings), National Office, Inland Revenue Department.

g6068

Determination DEP11: Tax Depreciation Rates General Determination Number 11

Pursuant to section EG 14 of the Income Tax Act 1994, notice is hereby given that the Commissioner of the Inland Revenue Department has issued “Determination DEP11: Tax Depreciation Rates General Determination Number 11”, pursuant to section EG 4 of the Income Tax Act 1994. The determination may be cited as “Determination DEP11: Tax Depreciation Rates General Determination Number 11”. The determination is available from Inland Revenue offices.

Dated at Wellington this 15th day of September 1995.